Upconversion Nanoparticles Get 150x Brighter and Can Tell Identical Molecules Apart

For most of the last half century, one problem has held back a family of extraordinarily clever nanoparticles. You could make them brighter, or you could make them useful, but not both at once. Researchers in Toronto now say they have found a way around that limit, producing upconversion nanoparticles that emit roughly 150 times more light than earlier versions of the same idea.

That matters because brightness is not a vanity metric in this field. It is the difference between a sensor that can find a trace pollutant in groundwater and one that cannot, and between a quality-control test that needs a laboratory instrument costing thousands of dollars per sample and one that could run off a cheap laser.

The work also does something that is genuinely hard: it tells apart molecules that contain exactly the same atoms in exactly the same numbers, arranged in a slightly different order. Those near-identical twins, known as structural isomers, are exactly the kind of subtle difference that causes problems in drug manufacturing.

Here is what the particles are, why they were stuck, and what changed.

What Are Upconversion Nanoparticles?

Upconversion nanoparticles, usually abbreviated UCNPs, are particles roughly 1 to 100 nanometers across that do something nature rarely does on demand. They absorb two or more low-energy photons in sequence and emit a single photon of higher energy. Light goes in at one color and comes out at a shorter wavelength, which is why the process is described as an anti-Stokes shift.

In practice that usually means a particle takes in invisible near-infrared light and gives back visible light. The apparent violation of ordinary light physics is not a trick or a violation. It relies on a specific property of certain rare earth elements: their internal electron energy levels are arranged so that an excited atom can hold onto energy for a very long time, long enough for a second low-energy photon to arrive and push it one step higher.

The technique is not new. The first demonstration came from French physicist François Auzel in 1966, who showed that an infrared photon could be converted into a visible one in glass co-doped with ytterbium and either erbium or thulium. That finding, in what was then solid-state lighting research, eventually became a distinct field of nanotechnology.

Particle upconversion is distinct from the other ways light can be shifted in energy. Downshifting moves a photon down, upconversion moves it up, and the full field is catalogued in reviews such as this one on the synthesis, mechanism and biological applications of upconversion nanomaterials.

How Upconversion Works: The Host, the Sensitizer and the Activator

Every upconversion nanoparticle is built from three components, and understanding the roles makes the whole thing easier to follow.

• The host lattice is the crystalline scaffolding that holds everything in place. The most widely used is sodium yttrium fluoride, written as NaYF4, because it does a good job of keeping the active ions spaced correctly.
• The sensitizer is the ion that catches the incoming light. Ytterbium is the usual choice because it absorbs near-infrared light efficiently, like a wide net catching a narrow stream of rain.
• The activator is the ion that finally releases the light as visible emission. Erbium, thulium, and holmium are the common activators, and swapping which one you use is how researchers produce different colors from the same basic recipe.

The relay works like this. The dye layer or the sensitizer absorbs the incoming near-infrared photon and hands its energy to a ytterbium ion. Ytterbium holds that energy in a long-lived excited state rather than releasing it immediately, which is the crucial trick. When a second photon arrives, ytterbium absorbs it too and climbs one step further up the energy ladder. Transfer the accumulated energy to an erbium ion sitting near the top of the ladder, and erbium drops back down, releasing the difference as green light.

Researchers describe several distinct routes for this energy climb, and the naming can get confusing. Energy transfer upconversion is the mechanism above and the most widely used, because lanthanide excited states last long enough to make a second absorption likely. Excited-state absorption achieves a similar result with a single ion. Photon avalanche relies on a kind of runaway in which one absorbed photon triggers the release of two, and the field also recognizes cooperative sensitization and energy migration between ions as separate processes.

Upconversion vs. Downconversion, and Why the Direction Matters

The opposite of upconversion is downconversion, and the distinction is not academic. It determines whether a particle is useful in the real world.

Downconversion is what almost every glowing thing around you does. A conventional fluorescent dye absorbs a high-energy photon, usually ultraviolet or blue light, and emits a lower-energy one. A red T-shirt absorbs blue and reflects red. This one-way direction is efficient and well understood, but it has a serious drawback for anyone trying to detect something.

The problem is that the sample itself lights up. Biological tissue, water, and most laboratory vessels all fluoresce under ultraviolet and short-wavelength excitation. That glow is background noise competing with the signal you actually care about, and it is why deep-tissue imaging has traditionally been so difficult.

Upconversion inverts the relationship. A particle excited by near-infrared light emits at a higher energy, so the exciting light sits at a completely different frequency from the emitted signal. Near-infrared light also travels through tissue with far less scattering and absorption than ultraviolet. The result, as Professor Kai Huang of the University of Toronto Engineering explains, is that shifting the excitation down to a lower frequency produces what he calls zero-autofluorescence background in the sample, so the dim glow the probes produce becomes readable. His analogy is the difference between stargazing at night and trying to see stars during the day, when the sun simply overwhelms them.

So the newer material wins decisively on background noise and tissue depth and typically loses on raw efficiency. That trade-off is why brightness work like this matters.

That is why the whole field is built around near-infrared excitation and why a design that produces genuinely zero autofluorescence background in the sample is such a significant result.

The Four Main Types of Nanoparticles

Upconversion nanoparticles sit inside a much larger family, and understanding the categories helps place the new work in context.

• Metallic nanoparticles, such as gold and silver particles, are defined by how electrons behave collectively at their surface. That surface plasmon resonance is what makes gold nanoparticles look red and is the basis of most lateral flow rapid test kits.
• Polymeric nanoparticles use polymers to encapsulate or carry other material, most often in drug delivery, where a particle needs to move through the body and release its cargo on command.
• Carbon-based nanoparticles, including carbon nanotubes and graphene, are valued for their mechanical strength, electrical conductivity, and unusual light absorption.
• Ceramic and lanthanide-doped nanoparticles are the upconversion family. The rare earth dopants supply the laddered energy levels that make photon upconversion possible, which is why the same rare earths that dominate permanent magnets and catalysts also turn up in these optical probes.

The Problem With Brightness: Low Quantum Yield

It is tempting to treat brightness as the only difficulty in making these particles useful. In practice, the binding constraint for most of the field’s history was something else entirely: low quantum yield.

Upconversion is an inefficient process by nature. The lanthanide transitions that make it work are, in quantum mechanical terms, forbidden, which means they are slow and lossy. Energy bleeds away as heat at every step. Until recently, the highest quantum yield on record for a conventional core-shell design based on sodium yttrium fluoride was around 9 percent, meaning that barely one photon in ten came back out as usable light.

Reviews of upconversion efficiency and its remaining limits, such as this one on enhancing the luminescence efficiency of these particles, treat the low quantum yield as the field’s central unresolved constraint.

For a bright light source that is disappointing but manageable. For a chemical sensor it is a serious problem, because a probe that converts very little of its input into output needs a large sample and a powerful laser, which is exactly the equipment a cheap field test is trying to avoid.

The Problem: The Brighter You Make Them, the Dimmer the Signal

The route researchers use to improve brightness creates its own contradiction, and understanding it is the key to the Toronto result.

To absorb more incoming light, you want as many ytterbium ions as possible packed into the particle. That seems obviously good. It is not.

Jiaze Wu, the doctoral student who led the new work, describes the problem as back-energy transfer. When ytterbium ions are packed densely, they stop discriminating about direction. They start absorbing not only the energy arriving from the incoming laser but also the energy trying to leave, the green light that the erbium ions have just produced. That energy gets bounced back into the ytterbium relay instead of escaping the particle surface, where it would have been measurable.

So the intuitive fix, more sensitiser ions, quietly undermines the signal. The field has been squeezed between an upper bound and a lower one: not enough ytterbium and the particle absorbs little light, too much, and it swallows its own output. Every attempt to escape that trade-off over the past decade has involved increasingly elaborate structures.

Earlier dye-sensitized designs, the family this work belongs to, wrapped a flat hexagonal particle in a shell of organic dye molecules. The researchers picture the arrangement as chocolate chips embedded in a cookie, with the dye molecules on the outside resembling icing. The dye does the initial capturing, passes energy to ytterbium as a relay, and hands it on to erbium, which performs the upconversion step and releases green light.

The Fix: A Three-Layer Particle That Works Like a One-Way Energy Tunnel

The new particles change both the recipe and the shape, and the two changes are linked.

The host matrix was switched from sodium, yttrium and fluorine to a lithium, lutetium and fluoride combination. Alongside that, the flat hexagonal particles were replaced with a more three-dimensional, diamond-shaped structure built from three distinct regions: a dense core, an inner shell, and an outer shell.

What makes it work is a deliberate gradient, and the direction of it is the opposite of what intuition suggests. The erbium that emits the light sits in the core, which is 98 percent ytterbium. The first shell is deliberately diluted back to 70 percent ytterbium by adding lutetium, and the outermost layer contains neodymium rather than ytterbium at all. Energy therefore runs into progressively fewer ytterbium relays as it travels outward.

There is a counterintuitive detail in how the design achieves this. Because the ytterbium network grows sparser toward the outside, an excited ion stranded in the outer layers has no continuous relay path to follow home, and the simulation shows energy starting at the very outside still ends up in the core better than nine times out of ten. Wu describes the arrangement as a one-directional energy tunnel, and he is candid that the team did not arrive at this by trial and error. They used Monte Carlo random-walk simulations and density functional theory to model how energy would move between the parts of a particle, down to the atomic and subatomic level, before building anything. That modelling is what showed the three-layer structure could work as a controlled one-way path for light.

The payoff was a reported output roughly 150 times brighter than upconversion nanoparticles that have not been dye-sensitized and about 50 times brighter than some of the most highly optimized conventional structures reported under the same excitation conditions.

And the dilution is not a rounding error. The three layers are 98 percent, then 70 percent, then neodymium. The middle step is 70 percent rather than 100 percent on purpose, and the supplementary data shows the fully ytterbium version actually emits less light, because a denser relay network in the middle shell funnels energy more efficiently than a diluted one.

Catching the Wrong Molecule in a Drug Batch

Brightness translates directly into one capability that conventional approaches struggle with: noticing tiny differences between similar things.

Structural isomers are the clearest example. These are molecules built from identical types and numbers of atoms, arranged differently in space. The composition is indistinguishable. The behavior is not always so.

Wu’s illustration is a hypothetical. Imagine a drug is being produced to specification, except that 10 percent of the batch is the wrong structural isomer. Wu’s point is that this is a serious defect: the isomer can make the drug less effective or, worse, produce side effects nobody predicted. Identifying it currently depends on very expensive analytical tests, and the hope is that a cheap laser and a very small sample could do the same job.

One detail makes the brightness especially useful. The particle only emits after binding to its target, so the glow itself is the signal, rather than a constant background the detector has to filter out. And because each nanoparticle produces such a strong optical signal, even a small number of particles attached to their target molecules generates enough light to detect. The same logic applies to environmental monitoring, where the challenge is often finding a contaminant at vanishingly low concentration inside a large volume of groundwater.

The practical hope is a probe customized to a specific target molecule, readable with a low-cost laser and a very small sample, instead of a laboratory instrument.

Where Upconversion Nanoparticles Are Already Being Used

The Toronto work sits inside a field with an unusually wide spread of active applications, most of them further along than the new chemical-sensing result.

• Deep-tissue imaging. Because near-infrared light penetrates tissue with less scattering and produces almost no background fluorescence, upconversion nanoparticles let researchers image structures far deeper than conventional dyes allow. Gd-based variants also work as contrast agents for CT and MRI.
• Photodynamic therapy. The particle acts as a local light source. It absorbs deeply penetrating near-infrared light and upconverts it to visible or ultraviolet wavelengths that activate a nearby photosensitizer, producing reactive oxygen species that destroy cancer cells. This reaches tissue that a conventional laser could not illuminate directly.
• Shrinking the light source to nanoparticle scale is a broader direction. One team has already built a nanolaser small enough to fit inside human cells, which points at the same goal of doing optical measurement at the scale and location where the biology happens.
• Drug delivery and triggered release. Attach a payload to the particle surface, and the same light-conversion trick can trigger its release at a chosen location rather than everywhere.
• Optogenetics. Brain tissue is difficult to image and difficult to stimulate. Converting an external near-infrared beam into localized visible light inside the tissue allows researchers to activate specific neurons remotely.
• Security inks and anti-counterfeiting. A mark written in an upconversion ink is invisible in ordinary light and reveals itself under near-infrared illumination, which is much harder to reproduce with printing than a visible pattern.
• It is the same trick behind plants engineered to detect explosives: give a material a light response it would not otherwise have, then read the result.
• Solar cells. Adding an upconversion layer lets a silicon cell capture near-infrared photons below its bandgap and convert them to wavelengths the cell can use.
• Temperature and pressure sensing, optical barcoding, three-dimensional display, data storage, and radiation curing of coatings round out the list.

What’s Still Missing Before This Becomes a Real Tool

The University of Toronto team is direct about the limits. Senior author Kai Huang describes the result as proof of concept and says manufacturing at scale is already under way but requires, in his words, a very long roadmap.

There are also field-wide problems that no single design solves. The record quantum yield for upconversion particles remains low in absolute terms because the underlying lanthanide transitions are intrinsically lossy, and efficiency is still traded against particle size. Excitation near 980 nanometers, historically the most convenient pump wavelength, carries a known risk of heating tissue, which has pushed much of the biomedical field toward longer wavelengths. Injecting a nanomaterial into a living body also demands far more long-term safety data than exists today, and standard good manufacturing practice production at scale is a separate hurdle from making a few impressive particles work in a dish.

The gap between laboratory demonstration and clinical use is a recurring theme. A recent review of upconversion nanoparticles in therapeutics research trends notes that translation remains limited by size-efficiency trade-offs, tissue heating under 980 nanometer excitation, regulatory production standards, and insufficient long-term biosafety data.

So the honest reading is that the 150-fold brightness gain is a real materials advance, not a product. It raises the ceiling for what upconversion probes can do, and the layered design that produced it is a genuinely new approach to a stubborn contradiction. Turning that into instruments that leave the laboratory is the part still ahead.

Frequently Asked Questions

Does upconversion break the laws of physics?

No. It appears to break them because it inverts the usual relationship between the energy of an absorbed photon and an emitted one. The trick is that it requires at least two low-energy photons to arrive before emission occurs, and it stores their combined energy in long-lived excited states of rare earth ions. A single photon is never converted into more energy than it brought in.

Why is it called photon upconversion rather than a normal light source?

Because a conventional light source, including an LED or a fluorescent dye, always emits at a longer wavelength than it absorbs. Upconversion emits at a shorter wavelength, so the word “up” refers to the energy of the emitted photon being higher than the energy that went in.

Why are ytterbium and erbium used together so often?

They play complementary roles. Ytterbium has a large absorption cross-section in the near-infrared, making it an efficient catcher of incoming light, but it emits weakly on its own. Erbium is a poor catcher but emits green light efficiently. Pairing them lets one do the collecting and the other do the signalling.

Are upconversion nanoparticles safe to put in the body?

Lanthanide-based particles are generally considered less toxic than heavy-metal alternatives such as cadmium-containing quantum dots, and they are chemically stable. But widespread clinical use still depends on long-term safety data, delivery methods and clearance from the body, so the majority of current work remains in research and diagnostic settings rather than routine treatment.

How do upconversion nanoparticles differ from quantum dots?

Both emit sharp, bright signals at chosen wavelengths. Quantum dots tend to be more efficient emitters and are widely used, but many contain cadmium or lead and can suffer photobleaching, where the signal fades under sustained illumination. Upconversion nanoparticles are noted for resistance to photobleaching, long emission lifetimes, and crucially, the ability to be excited with near-infrared light, which produces almost no background fluorescence in biological samples.

Can you buy upconversion nanoparticles?

They are sold as research materials, with some formats available from chemical suppliers in milligram quantities. Nothing in the Toronto work is commercially available; the team describes manufacturing at scale as a long-term project. Any consumer product based on these particles, such as a security-printed label, would depend on far cheaper production methods than currently exist.

What the Brighter Particles Actually Change

Upconversion nanoparticles have spent decades as a scientific curiosity with a low efficiency ceiling. The Toronto result is interesting less for the number itself than for how it was reached, because it attacked a contradiction rather than a shortage. More light-absorbing ions had always meant less light leaving the particle, and the whole design exists to break that link.

The layered structure in these new particles, with ytterbium growing sparser toward the outside, makes the inward path the easy one for energy to take. The particles capture more incoming light without reclaiming more of the output, and the structure was found by simulation before any of it was built, which suggests the approach generalizes beyond the one recipe.

What that unlocks is straightforward to state. A probe bright enough to read with a cheap laser, on a small sample, that can tell a correct drug molecule from a subtly wrong one, is a different kind of instrument from the laboratory analysis it would replace. Turning that into something reliable, manufacturable, and affordable is the remaining distance between a record and a tool.